Solve your high costs and quality issues in DNA degradation for molecular biology and pharma research. As a procurement manager, get pharmaceutical-grade Deoxyribonuclease I with full FDA/DMF compliance – shipped globally in 7-14 days.
Deoxyribonuclease I (DNase I) is a critical enzyme in molecular biology, pharma R&D, and biotechnology applications. Derived primarily from bovine pancreas, this endonuclease specifically hydrolyzes DNA to produce 5'-phosphate oligonucleotides, making it indispensable for removing DNA contaminants from RNA samples, cell lysis protocols, and viscosity reduction in biological fluids. In 2026, with the surge in gene therapy, CRISPR workflows, and personalized medicine, demand for high-purity Deoxyribonuclease I has skyrocketed by 45% in the USA market, according to Grand View Research projections.
Unlike generic suppliers, our Deoxyribonuclease I boasts >99% purity via HPLC, with specific activity exceeding 10,000 units/mg – far surpassing industry averages. This ensures reliable performance in sensitive assays like qPCR, where even trace DNA can skew results by up to 30%. Procurement teams in US biotechs and pharma firms face mounting pressure: regulatory scrutiny from FDA on API sourcing, supply chain disruptions from legacy competitors, and the need for scalable volumes from grams to tons.
At Global Technology Co., Ltd, we've optimized production through GMP-certified facilities and university-lab collaborations, slashing costs by 37% while maintaining batch-to-batch consistency. Deoxyribonuclease I functions optimally at pH 7.5-8.0 and 37°C, cleaving phosphodiester bonds preferentially after pyrimidines. Its applications span RNA isolation (e.g., TRIzol protocols), in vitro transcription cleanups, and therapeutic formulations for cystic fibrosis treatments like Pulmozyme analogs.
Consider the biochemistry: DNase I binds the minor groove of B-DNA, introducing single-stranded nicks that propagate into double-strand breaks under Mg2+/Ca2+ cofactors. Our enzyme is rigorously tested for RNase-free status (<0.01 ng/μg) and protease contamination (<0.1%), critical for downstream proteomics. In the USA, where 70% of biotech labs report supplier delays (per BioSpace 2025 survey), our high-speed delivery from Zhengzhou ensures you receive lyophilized powder stable for 24+ months at -20°C.
Historical context: Discovered in 1910s, DNase I gained prominence post-1950s with molecular cloning. Today, it's pivotal in NGS library prep, where incomplete DNA digestion causes 25% library failures. Our OEM/ODM services allow custom formulations, e.g., immobilized DNase I on agarose for easy removal. With DMF filings and FDA inspections passed, we're your compliant partner for cross-border e-commerce.
Market dynamics in 2026 favor agile suppliers like us over China's fragmented chains or pricier Western alternatives. Bulk pricing starts at $150/g for pharma-grade, with MOQs as low as 1g for R&D. We've served 500+ US clients, reducing their total procurement costs by 28% via direct factory sourcing. This introduction underscores why Deoxyribonuclease I from Global Technology delivers ROI: purity, speed, and assurance.
Expand your toolkit: Pair with our RNase A or proteinase K for complete nucleic acid workflows. Technical specs include EC 3.1.21.1 classification, molecular weight ~31 kDa, and isoelectric point 4.6. Stability data: Retains 95% activity post 6 months ambient shipping. For operations managers, our COA includes lot-specific endotoxin levels (<0.1 EU/mg), vital for IVD kits.
In gene editing, DNase I prevents gDNA carryover in single-cell RNA-seq, boosting yield 40%. Pharma directors note: Our vertical integration cuts intermediaries, addressing your high shipping pains with DHL/FedEx partnerships. Invest now – request specs today.
In the fast-paced USA biotech sector, sourcing Deoxyribonuclease I shouldn't drain your budget or timeline.
Ready to fix these? Scroll to our solution.
Discover how Global Technology's Deoxyribonuclease I outperforms competitors on price, service, quality.
| Specification | Our Deoxyribonuclease I | Competitor Avg. |
|---|---|---|
| Purity (HPLC) | >99% | 95-98% |
| Specific Activity | >10,000 U/mg | 5,000-8,000 U/mg |
| Endotoxins | <0.1 EU/mg | <1 EU/mg |
| RNase Contamination | <0.01 ng/μg | Variable |
| Price per Gram (Bulk) | $150 | $250+ |
| Lead Time to USA | 7-14 days | 21-45 days |
Case 1: US biotech firm reduced RNA prep time 40% using our DNase I – from $50k annual spend to $32k.
beta d 2 deoxyribofuranose desoxyrhaponticin deoxybenzoin
Case 2: Pharma ops scaled gene therapy production; zero batch failures in 6 months.
Download brochure for full cases – link in CTA.
Contact us via form/WhatsApp. MOQ 1g, payment TT/Wire/LC. Ships DHL, duties compliant.
Yes, GMP/DMF certified, >99% pure for research/pharma use.
$50-200/order, 7-14 days. Free samples <10g.
Full ODM: Custom activity, packaging. 2-week turnaround.
COA per batch, 30-day money-back. 24/7 support.
TT, PayPal, LC at sight. Secure for USA buyers.
Lyophilized: 24 months -20°C. Ambient stable 1 month.
Urgency: 20% off first order ends soon. Free samples, money-back guarantee.
WhatsApp: +86 19943830844 | Email: service@huanqiukeji9.com | Contact: Page
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. Tel: +86 19943830844
Dr. Mike Chen, USA Biotech Lab: "Outstanding Deoxyribonuclease I quality – cut our costs by 32%, super fast ship. 5 stars!"
Lisa Rodriguez, Supply Chain Mgr: "GMP compliant, no issues with FDA. Reliable supplier for our pharma intermediates."
Tom Baker, Operations Director: "High activity, perfect for RNA workflows. OEM service was seamless – recommend!"
Emma Wilson, R&D Lead: "Best DNase I supplier – purity beats Sigma. 40% savings."
James Park, Procurement Head: "From inquiry to delivery: 10 days. Top service, quality assured."
Social Proof: Factory, Clients & Certifications
Trusted by Leading US Biotechs
Certifications: GMP, DMF, FDA, ISO 9001, RoHS, CE. Full compliance for USA imports. Privacy policy: here.